Clinical and genetic analyses of 150 patients with paroxysmal kinesigenic dyskinesia
- PMID: 35428900
- DOI: 10.1007/s00415-022-11103-0
Clinical and genetic analyses of 150 patients with paroxysmal kinesigenic dyskinesia
Abstract
Background: Mutations in PRRT2 and 16p11.2 microdeletion including PRRT2 have been identified as the pathogenic cause of paroxysmal kinesigenic dyskinesia (PKD).
Objective: The objective was to investigate the clinical and genetic features of PKD and to analyze the genotype-phenotype correlation.
Methods: We recruited PKD patients, recorded clinical manifestations, and performed PRRT2 screening in 150 PKD patients by unified PKD registration forms. Genotype-phenotype correlation analyses were conducted in probands. High-knee-exercise (HKE) tests were applied in one hundred and six patients.
Results: Eight PRRT2 mutations were detected, accounting for 22.76% of the probands. Three mutations (c.649dupC, c.649delC, and c.510_513delTCTG) were already reported, while four mutations (c.252_264delCACAGACCTCAGC, c.503_504delCT, c.679C > T, and c.804C > A) were first reported. One heterozygous microdeletion of 606 kb in 16p11.2 was detected in one patient. Compared with non-PRRT2 mutation carriers, the PRRT2 mutation carriers were younger at onset, experienced longer attacks, and tended to present with complicated PKD, combined phenotypes of dystonia and chorea. 57.01% of patients could effectively induce movement disorders through the HKE test. A good response was shown in 81.93% of the patients prescribed with antiepileptic drugs. 13.54% (13/96) had abnormal EEG results.
Conclusions: PRRT2 mutations are common in patients with PKD and are significantly associated with an earlier age at onset, longer duration of attacks, a complicated form of PKD, combined phenotypes of dystonia and chorea. Patients with microdeletion of 16p11.2 may have more severe manifestations. The HKE test could contribute to the diagnosis of PKD. Carbamazepine is still the first choice for PKD patients, but individualized treatment should be formulated.
Keywords: 16p11.2 Microdeletion; Genotype–phenotype correlation; PRRT2; Paroxysmal kinesigenic dyskinesia.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Similar articles
-
Paroxysmal kinesigenic dyskinesia: Clinical and genetic analyses of 110 patients.Neurology. 2015 Nov 3;85(18):1546-53. doi: 10.1212/WNL.0000000000002079. Epub 2015 Oct 7. Neurology. 2015. PMID: 26446061
-
Genotype-phenotype correlation in a cohort of paroxysmal kinesigenic dyskinesia cases.J Neurol Sci. 2014 May 15;340(1-2):91-3. doi: 10.1016/j.jns.2014.02.034. Epub 2014 Mar 3. J Neurol Sci. 2014. PMID: 24661410
-
Clinico-genetic comparisons of paroxysmal kinesigenic dyskinesia patients with and without PRRT2 mutations.Eur J Neurol. 2014 Apr;21(4):674-8. doi: 10.1111/ene.12142. Epub 2013 Mar 29. Eur J Neurol. 2014. PMID: 23551744
-
PRRT2 mutations in a cohort of Chinese families with paroxysmal kinesigenic dyskinesia and genotype-phenotype correlation reanalysis in literatures.Int J Neurosci. 2018 Aug;128(8):751-760. doi: 10.1080/00207454.2017.1418345. Epub 2018 Jan 7. Int J Neurosci. 2018. PMID: 29285950 Review.
-
PRRT2-related disorders: further PKD and ICCA cases and review of the literature.J Neurol. 2013 May;260(5):1234-44. doi: 10.1007/s00415-012-6777-y. Epub 2013 Jan 9. J Neurol. 2013. PMID: 23299620 Review.
Cited by
-
Genetic and phenotypic analyses of PRRT2 positive and negative paroxysmal kinesigenic dyskinesia.Ther Adv Neurol Disord. 2024 Jan 18;17:17562864231224110. doi: 10.1177/17562864231224110. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 38250317 Free PMC article.
-
TMEM151A variants associated with paroxysmal kinesigenic dyskinesia.Hum Genet. 2023 Aug;142(8):1017-1028. doi: 10.1007/s00439-023-02535-3. Epub 2023 Mar 1. Hum Genet. 2023. PMID: 36856871
References
-
- Kertesz A (1967) Paroxysmal kinesigenic choreoathetosis. An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied. Neurology 17(7):680–690. https://doi.org/10.1212/wnl.17.7.680 - DOI - PubMed
-
- Bruno MK, Hallett M, Gwinn-Hardy K, Sorensen B, Considine E, Tucker S, Lynch DR, Mathews KD, Swoboda KJ, Harris J et al (2004) Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology 63(12):2280–2287. https://doi.org/10.1212/01.wnl.0000147298.05983.50 - DOI - PubMed
-
- Wang JL, Cao L, Li XH, Hu ZM, Li JD, Zhang JG, Liang Y, San A, Li N, Chen SQ et al (2011) Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain 134(Pt 12):3493–3501. https://doi.org/10.1093/brain/awr289 - DOI - PubMed
-
- Bhatia KP, Schneider SA (2012) Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesia. Mov Disord 27(6):707. https://doi.org/10.1002/mds.25038 - DOI - PubMed
-
- Chen WJ, Lin Y, Xiong ZQ, Wei W, Ni W, Tan GH, Guo SL, He J, Chen YF, Zhang QJ et al (2011) Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet 43(12):1252–1255. https://doi.org/10.1038/ng.1008 - DOI - PubMed
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical